Semanteon Capital Management LP bought a new position in Molina Healthcare, Inc. (NYSE:MOH – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 866 shares of the company’s stock, valued at approximately $313,000.
A number of other large investors have also added to or reduced their stakes in the stock. Deutsche Bank AG grew its holdings in shares of Molina Healthcare by 1.5% in the third quarter. Deutsche Bank AG now owns 258,441 shares of the company’s stock worth $84,740,000 after acquiring an additional 3,754 shares during the period. Invesco Ltd. grew its stake in shares of Molina Healthcare by 10.4% during the 3rd quarter. Invesco Ltd. now owns 1,190,161 shares of the company’s stock valued at $390,242,000 after purchasing an additional 112,243 shares during the period. Assenagon Asset Management S.A. increased its position in shares of Molina Healthcare by 4,019.2% during the 4th quarter. Assenagon Asset Management S.A. now owns 103,185 shares of the company’s stock valued at $37,282,000 after purchasing an additional 100,680 shares during the last quarter. DNB Asset Management AS lifted its stake in shares of Molina Healthcare by 20.7% in the 4th quarter. DNB Asset Management AS now owns 42,852 shares of the company’s stock worth $15,483,000 after purchasing an additional 7,346 shares during the period. Finally, Principal Financial Group Inc. grew its position in Molina Healthcare by 0.5% during the third quarter. Principal Financial Group Inc. now owns 74,056 shares of the company’s stock valued at $24,282,000 after buying an additional 376 shares during the period. Institutional investors own 98.50% of the company’s stock.
Molina Healthcare Price Performance
Shares of MOH stock opened at $342.23 on Friday. The stock has a 50 day moving average price of $390.34 and a 200 day moving average price of $371.90. The firm has a market capitalization of $20.05 billion, a P/E ratio of 18.57, a P/E/G ratio of 0.99 and a beta of 0.47. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.54 and a current ratio of 1.49. Molina Healthcare, Inc. has a 52-week low of $266.35 and a 52-week high of $423.92.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the stock. Truist Financial lifted their price target on shares of Molina Healthcare from $435.00 to $460.00 and gave the stock a “buy” rating in a research note on Tuesday, February 20th. Cantor Fitzgerald reiterated an “overweight” rating and set a $406.00 target price on shares of Molina Healthcare in a research report on Thursday, April 4th. Wells Fargo & Company reduced their price target on Molina Healthcare from $440.00 to $410.00 and set an “equal weight” rating for the company in a research report on Monday, April 15th. Barclays lowered their price objective on Molina Healthcare from $437.00 to $430.00 and set an “equal weight” rating on the stock in a research report on Thursday. Finally, StockNews.com lowered shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 8th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Molina Healthcare has an average rating of “Hold” and a consensus target price of $396.09.
Insider Activity
In related news, Director Richard M. Schapiro sold 711 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the completion of the sale, the director now owns 12,207 shares in the company, valued at $4,688,220.42. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Richard M. Schapiro sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total transaction of $401,050.00. Following the transaction, the director now directly owns 11,207 shares of the company’s stock, valued at $4,494,567.35. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Richard M. Schapiro sold 711 shares of the company’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the sale, the director now owns 12,207 shares of the company’s stock, valued at approximately $4,688,220.42. The disclosure for this sale can be found here. Over the last quarter, insiders sold 16,711 shares of company stock valued at $6,472,517. Corporate insiders own 1.10% of the company’s stock.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories
- Five stocks we like better than Molina Healthcare
- What is Short Interest? How to Use It
- MarketBeat Week in Review – 4/22 – 4/26
- Which Wall Street Analysts are the Most Accurate?
- 3 Stocks Leading the U.S. Agriculture Comeback
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- How to Use Put Debit Spreads to Profit From Falling Stocks
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.